Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,996 | 178 | 87.6% |
| Education | $422.18 | 6 | 12.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $754.21 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $422.00 | 13 | $0 (2024) |
| Amgen Inc. | $414.52 | 23 | $0 (2022) |
| PFIZER INC. | $328.73 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $318.90 | 20 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $274.26 | 9 | $0 (2023) |
| Celgene Corporation | $153.03 | 10 | $0 (2019) |
| Genentech USA, Inc. | $128.71 | 6 | $0 (2019) |
| UCB, Inc. | $84.16 | 3 | $0 (2023) |
| Lilly USA, LLC | $75.88 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $218.71 | 7 | ABBVIE INC. ($113.21) |
| 2023 | $485.81 | 22 | Novartis Pharmaceuticals Corporation ($161.79) |
| 2022 | $332.65 | 19 | ABBVIE INC. ($149.01) |
| 2021 | $329.35 | 14 | SUN PHARMACEUTICAL INDUSTRIES INC. ($152.71) |
| 2020 | $136.83 | 8 | PFIZER INC. ($35.42) |
| 2019 | $719.67 | 34 | AbbVie, Inc. ($142.79) |
| 2018 | $572.98 | 39 | AbbVie, Inc. ($142.23) |
| 2017 | $622.10 | 41 | Amgen Inc. ($127.21) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Immunology | ||||||
| 03/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: IMMUNOLOGY | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Dermatology | ||||||
| 02/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $37.47 | General |
| Category: Dermatology | ||||||
| 11/20/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Immunology | ||||||
| 10/24/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Immunology | ||||||
| 09/18/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Dermatology | ||||||
| 08/15/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: DERMATOLOGY | ||||||
| 07/17/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: DERMATOLOGY | ||||||
| 07/14/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Dermatology | ||||||
| 06/30/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 06/12/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Dermatology | ||||||
| 06/12/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Dermatology | ||||||
| 05/15/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.78 | General |
| 04/21/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Dermatology | ||||||
| 04/19/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: Dermatology | ||||||
| 04/17/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Immunology | ||||||
| 04/04/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,818 | 9,116 | $383,545 | $231,115 |
| 2022 | 15 | 3,506 | 7,884 | $360,693 | $207,245 |
| 2021 | 15 | 3,938 | 9,040 | $405,902 | $242,035 |
| 2020 | 13 | 3,697 | 8,605 | $313,294 | $189,418 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 906 | 1,107 | $103,721 | $57,581 | 55.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 649 | 802 | $89,883 | $56,619 | 63.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 714 | 1,025 | $50,750 | $30,291 | 59.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 567 | 5,101 | $34,176 | $21,666 | 63.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 350 | 375 | $32,013 | $20,093 | 62.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 147 | 147 | $17,207 | $9,846 | 57.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 185 | 206 | $12,021 | $6,752 | 56.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 48 | $8,287 | $5,443 | 65.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 39 | 43 | $7,814 | $5,146 | 65.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 43 | 50 | $6,815 | $4,566 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 52 | $6,906 | $4,046 | 58.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 65 | 78 | $4,015 | $2,643 | 65.8% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $3,701 | $2,450 | 66.2% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 19 | 21 | $3,094 | $2,160 | 69.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 42 | 42 | $3,143 | $1,815 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 918 | 1,125 | $109,154 | $59,503 | 54.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 576 | 724 | $84,393 | $50,102 | 59.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 654 | 898 | $48,271 | $27,853 | 57.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 520 | 4,233 | $29,752 | $17,876 | 60.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 313 | 334 | $29,324 | $17,373 | 59.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 123 | 123 | $14,836 | $7,318 | 49.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 158 | 169 | $10,187 | $5,893 | 57.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 35 | 40 | $7,501 | $5,009 | 66.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 45 | 51 | $6,951 | $4,558 | 65.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 53 | $7,258 | $3,895 | 53.7% |
About Dr. Jamie Frey, MD
Dr. Jamie Frey, MD is a Dermatology healthcare provider based in Peoria, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639391006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamie Frey, MD has received a total of $3,418 in payments from pharmaceutical and medical device companies, with $218.71 received in 2024. These payments were reported across 184 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,996).
As a Medicare-enrolled provider, Frey has provided services to 14,959 Medicare beneficiaries, totaling 34,645 services with total Medicare billing of $869,813. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Peoria, IL
- Active Since 05/03/2007
- Last Updated 07/15/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1639391006
Products in Payments
- Enbrel (Biological) $349.85
- SKYRIZI (Biological) $324.46
- Humira (Biological) $321.49
- EUCRISA (Drug) $313.46
- TREMFYA (Drug) $206.00
- COSENTYX (Drug) $156.52
- COSENTYX (Biological) $141.60
- Tremfya (Drug) $139.14
- Erivedge (Biological) $128.71
- ILUMYA (Biological) $88.19
- REMICADE (Biological) $76.86
- TALTZ (Drug) $75.88
- DUPIXENT (Drug) $70.66
- Cimzia (Drug) $64.76
- Otezla (Drug) $64.67
- Ilumya (Biological) $52.72
- Topicort (Drug) $52.61
- Finacea (Drug) $49.50
- Skyrizi (Biological) $45.84
- DUPIXENT (Biological) $41.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Peoria
Dr. Troy Ellis, Md, MD
Dermatology — Payments: $14,369
Dane Hill, Md, MD
Dermatology — Payments: $11,391
Dr. Julie Jacobs, D.o, D.O
Dermatology — Payments: $11,061
Dr. Carl Soderstrom, M.d, M.D
Dermatology — Payments: $10,038
Mary Fredenberg, Md, MD
Dermatology — Payments: $9,727
Rachel Cetta, Do, DO
Dermatology — Payments: $9,047